Research & Development
Bio Gene Ltd
Bio Gene Ltd
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Assessing the risks: the importance of a multifaceted approach to containment
Risk assessment is a crucial component of any manufacturing process and plays a key role in terms of ensuring the well-being of workers and the quality of products, reports...
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Anti-IL-21 monoclonal antibody licensed by Almirall
NN-8828, the IL-21 blocker, is exclusively owned by Almirall and will be used to treat immune inflammatory dermatological diseases
Fresenius Kabi receives approval for tocilizumab biosimilar Tyenne
The Interleukin-6 antagonist can be used to treat various inflammatory and immune mediated conditions
Pharma Sustainability Integrates
28 February 2024 | Conference | London, UK
GlobalData names top 25 global pharma companies by market cap
The performance highlights of the top 25 publicly traded global pharma companies for the year 2017 have been confirmed in the latest research from GlobalData